Arcus Biosciences, Inc. announced that Jennifer Jarrett will step down as the company's Chief Financial and Operating Officer, effective January 11, 2019, to pursue an opportunity at a privately-held transportation and technology company. Ms. Jarrett will remain actively engaged with the company and has been appointed to company's Board of Directors commencing January 12, 2019.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.84 USD | +2.72% |
|
+12.61% | -16.99% |
07-09 | Arcus Biosciences Says Taiho Has Exercised Option for Exclusive License to Quemliclustat in Japan | MT |
07-05 | Sector Update: Health Care Stocks Advance in Afternoon Trading | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.99% | 1.4B | |
+24.28% | 46.56B | |
+45.66% | 41.67B | |
-0.34% | 41.16B | |
+33.62% | 32.4B | |
+20.46% | 28.18B | |
-6.35% | 28.1B | |
+49.59% | 14.52B | |
+47.78% | 13.74B | |
+2.07% | 12.17B |
- Stock Market
- Equities
- RCUS Stock
- News Arcus Biosciences, Inc.
- Arcus Biosciences, Inc. Announces Management Changes